
Bloom is expanding beyond mobility into an AI-powered U.S. manufacturing marketplace for drones, robotics, and hardware startups.
A Crunchbase News guest article by Antonia Dean argues that founders should build cap tables intentionally, prioritizing investors who bring strategic access, stage-specific expertise and trusted guidance—not just capital.

Antonia Dean’s central point is direct: raising venture capital means choosing who will own part of the company, not simply securing money. Investors can later gain influence over major decisions, including fundraising, acquisitions and leadership changes. Founders should therefore treat cap table construction as a strategic decision, not a scramble to include anyone willing to invest.
Founders should ask what each investor can materially help the company accomplish over the next 18 to 24 months. The article points to examples such as fintech investors with access to banks, regulators or payment companies, healthcare investors connected to hospital systems or insurers, and consumer-products investors who understand distribution or retail partnerships. The practical takeaway: verify support through portfolio-founder references and evidence, not promises.
Dean argues that impressive résumés are not enough if an investor does not understand the company’s current phase. Pre-seed, seed and Series A startups face different challenges, from market validation to hiring, repeatability and scaling. Stage-specific investors can help founders understand likely next-round expectations, common mistakes and the milestones that matter before returning to market.

The article emphasizes that founders need at least one investor they genuinely trust when things go wrong. That person should be someone the founder can call before a polished explanation is ready, especially during revenue misses, co-founder disagreements, executive departures, product failures or slower-than-expected fundraising. Before closing a round, founders should check whether the cap table includes industry knowledge, stage expertise and a trusted adviser.

Bloom is expanding beyond mobility into an AI-powered U.S. manufacturing marketplace for drones, robotics, and hardware startups.

The healthtech startup is scaling AI that flags hospital patients for closer review without making diagnoses.

The AI cloud startup is seeking up to $4B before a planned 2027 IPO.

Benchmark backs Furientis’ push to mass-produce low-cost missile interceptors.